Fate Therapeutics
FATE
#7766
Rank
A$0.36 B
Marketcap
$3.18
Share price
-6.76%
Change (1 day)
-14.83%
Change (1 year)

EPS for Fate Therapeutics (FATE)

EPS in 2023 (TTM): -$3.27

According to Fate Therapeutics 's latest financial reports the company's current EPS (TTM) is -$3.33. In 2022 the company made an earnings per share (EPS) of -$4.47 a decrease over its 2021 EPS that were of -$3.42.

EPS history for Fate Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.27-26.8%
2022-$4.4730.49%
2021-$3.427.21%
2020-$3.1945.45%
2019-$2.2019.17%
2018-$1.8417.65%
2017-$1.57-3.77%
2016-$1.63-12.4%
2015-$1.86-3.97%
2014-$1.93-2.09%
2013-$1.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$12.02 260.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.52-355.76%๐Ÿ‡บ๐Ÿ‡ธ USA
-$13.28 298.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.76 42.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.01-190.32%๐Ÿ‡บ๐Ÿ‡ธ USA